PAIM
CMD

Punch & Associates Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Punch & Associates Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,154
Closed -$686K – 209
2018
Q1 		$686K Buy
6,154
+5
+0.1% +$560 0.06% 171
2017
Q4 		$633K Buy
6,149
+2,594
+73% +$258K 0.05% 177
2017
Q3 		$335K Buy
3,555
+830
+30% +$65.5K 0.03% 178
2017
Q2 		$212K Buy
+2,725
New +$205K 0.02% 181

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Punch & Associates Investment Management's CMD Position: Q2 2018 in Review

Punch & Associates Investment Management sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 6,154 shares — an estimated $686K sold.

Punch & Associates Investment Management first reported a position in CMD in Q2 2017 and held it in 4 quarters. The position peaked at $686K in Q1 2018. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

  • Punch & Associates Investment Management reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
  • Punch & Associates Investment Management sold 6,154 Cantel Medical Corporation shares in Q2 2018, an estimated $686K.
  • Punch & Associates Investment Management first reported a position in Cantel Medical Corporation in Q2 2017 and held it in 4 quarters.
  • Punch & Associates Investment Management's Cantel Medical Corporation position peaked at $686K in Q1 2018.
  • 292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Punch & Associates Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.